Lisa DeFrancesco's most recent trade in Lexicon Pharmaceuticals Inc was a trade of 24,673 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | Lisa DeFrancesco | SVP, IR and Corp Comm | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 24,673 | 49,347 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Lisa DeFrancesco | SVP, IR and Corp Comm | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 24,673 | 24,673 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | Lisa DeFrancesco | SVP, IR and Corp Comm | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 28 Feb 2025 | 9,096 | 15,577 (0%) | 0% | 0.7 | 6,094 | Common Stock |
| Lexicon Pharmaceuticals Inc | Lisa DeFrancesco | VP, IR and Corp Comm | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 576,850 | 576,850 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Lisa DeFrancesco | VP, IR and Corp Comm | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 384,570 | 384,570 | - | - | Restricted Stock Units | |
| Intercept Pharmaceuticals Inc | Lisa DeFrancesco | SVP, IR & Corp. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.85 per share. | 30 Sep 2021 | 204 | 10,850 (0%) | 0% | 14.8 | 3,029 | Common Stock |
| Intercept Pharmaceuticals Inc | Lisa DeFrancesco | SVP, IR & Corp. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.05 per share. | 01 Sep 2021 | 538 | 11,054 (0%) | 0% | 15.1 | 8,097 | Common Stock |